About
Dan Amos is chairman and chief executive officer of Aflac Incorporated. He is one of the longest-serving CEOs in the Fortune 200, and his innovative leadership style has led to astounding annual revenue growth from $2.7 billion in 1990 to $22.1 billion in 2021. Today, Aflac is a Fortune 500 company, helping provide protection to more than 50 million people through its subsidiaries in Japan and the U.S. by paying cash fast when policyholders get sick or injured. For more than six decades, insurance policies of Aflac Incorporated’s subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. In Japan, Aflac is the leading provider of medical and cancer insurance in Japan and insures one in four households. In the U.S., Aflac is the number one provider supplemental health insurance products1. In January 2000, Dan launched the popular Aflac Duck advertising campaign, transforming Aflac from a successful supplemental insurance company to a top international brand recognized by FORTUNE magazine as one of the World’s Most Admired Companies for 21 years. His commitment to ethical business practices has led the Ethisphere Institute to recognize Aflac Incorporated as a World’s Most Ethical Company for 16 consecutive years, making Aflac the only insurance company in the world to appear on this list every year since the inception of the award in 2007. Dan has also appeared five times on Institutional Investor magazine’s lists of America’s Best CEOs for the insurance category, and he has been recognized as one of the 100 Best-Performing CEOs in the World by the Harvard Business Review five times. Under Dan’s leadership, Aflac Incorporated was included in the Bloomberg Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation and transparency, for the third consecutive year in 2021. In 2021, the company was also included in the Dow Jones Sustainability North America Index and became a signatory of the Principles for Responsible Investment (PRI). In 1995, Dan inspired Aflac’s decades-long commitment to helping families of children diagnosed with cancer. The company and its independent sales associates have contributed more than $157 million to this cause, including funding for the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, which has become a leading childhood cancer facility in the United States as rated by U.S. News and World Report. In taking this commitment to the next level, Dan has been a driving force behind the introduction of My Special Aflac Duck, the company’s social robot that uses medical play, lifelike movement and emotions to engage and help comfort kids during their cancer care and most recently, sickle cell disease treatment. In December 2018, TIME magazine named My Special Aflac Duck as one of the “Best Inventions of 2018.” In 2013, Dan proudly accepted the Salute to Greatness Award from the Dr. Martin Luther King Jr. Center in Atlanta, joining a distinguished list of past recipients, including Ambassador Andrew J. Young, U.S. Poet Laureate Maya Angelou, Ervin “Magic” Johnson, and musicians Bono and Stevie Wonder. He has also received the Anti-Defamation League’s Torch of Liberty Award. A past member of the board of trustees of Children’s Healthcare of Atlanta, Dan serves on the board of the House of Mercy of Columbus in Georgia. He is former chairman of the board of the Japan America Society of Georgia and the University of Georgia Foundation. Dan joined Aflac in 1973, working in sales for 10 years. In 1983, he was named president of Aflac and was later promoted to chief operating officer in 1987. He became chief executive officer of Aflac Incorporated in 1990 and chair of the board of directors in 2001. He holds a bachelor’s degree in insurance and risk management from the University of Georgia. 1 LIMRA 2021 U.S. Supplemental Health Insurance Total Market Report
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Aflac | Board | Chairperson | 01/01/2001 |